KR20020072486A - 위장내 헬리코박터 피로리 감염균의 감소 및 증식억제능이 있는 요구르트 조성물 - Google Patents
위장내 헬리코박터 피로리 감염균의 감소 및 증식억제능이 있는 요구르트 조성물 Download PDFInfo
- Publication number
- KR20020072486A KR20020072486A KR1020010023789A KR20010023789A KR20020072486A KR 20020072486 A KR20020072486 A KR 20020072486A KR 1020010023789 A KR1020010023789 A KR 1020010023789A KR 20010023789 A KR20010023789 A KR 20010023789A KR 20020072486 A KR20020072486 A KR 20020072486A
- Authority
- KR
- South Korea
- Prior art keywords
- helicobacter pylori
- lactobacillus
- yogurt
- yoghurt
- gastric
- Prior art date
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 45
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 37
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 29
- 230000012010 growth Effects 0.000 title description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 230000000694 effects Effects 0.000 claims abstract description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 21
- 239000004310 lactic acid Substances 0.000 claims abstract description 15
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 15
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 11
- 235000016887 Leptospermum scoparium Nutrition 0.000 claims abstract description 10
- 229920000175 Pistacia lentiscus Polymers 0.000 claims abstract description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 230000008929 regeneration Effects 0.000 claims abstract description 9
- 238000011069 regeneration method Methods 0.000 claims abstract description 9
- 241000186660 Lactobacillus Species 0.000 claims abstract description 8
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 8
- 241000186675 Weissella confusa Species 0.000 claims abstract description 8
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 7
- 241001546092 Coprophilus Species 0.000 claims abstract description 6
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 6
- 230000002496 gastric effect Effects 0.000 claims description 32
- 230000006870 function Effects 0.000 claims description 25
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 18
- 235000013824 polyphenols Nutrition 0.000 claims description 18
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 10
- 229930182816 L-glutamine Natural products 0.000 claims description 7
- 241000219094 Vitaceae Species 0.000 claims description 4
- 235000021021 grapes Nutrition 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 230000001028 anti-proliverative effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 26
- 230000002147 killing effect Effects 0.000 abstract description 14
- 210000002784 stomach Anatomy 0.000 abstract description 13
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 239000000284 extract Substances 0.000 abstract description 4
- 239000005445 natural material Substances 0.000 abstract description 3
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 238000009472 formulation Methods 0.000 description 19
- 150000003254 radicals Chemical class 0.000 description 13
- 230000006872 improvement Effects 0.000 description 11
- 241000208340 Araliaceae Species 0.000 description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 9
- 239000004202 carbamide Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 210000002919 epithelial cell Anatomy 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000018522 Gastrointestinal disease Diseases 0.000 description 5
- 210000001156 gastric mucosa Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 206010019375 Helicobacter infections Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229940038487 grape extract Drugs 0.000 description 4
- 239000008204 material by function Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000589562 Brucella Species 0.000 description 2
- 241000237970 Conus <genus> Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000024330 bloating Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- -1 green tea and grapes Chemical class 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017964 Gastrointestinal infection Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000001437 anti-cataract Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000008198 composition by function Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000019836 digestive system infectious disease Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000004203 pyloric antrum Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940119569 wormwood extract Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/137—Thickening substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
배합소재 | 배합1 | 배합2 | 배합3 | 배합4 | 배합5 | 배합6 | 배합7 | 배합8 | |
사멸기능 | 마스틱검 파우더(마스틱검 함량 10%) | 3.3 | 3.3 | 1.65 | 1.65 | 1.65 | - | 1.65 | 1.65 |
마누카꿀 | - | - | 3.0 | 3.0 | - | 3.0 | 0.1 | 0.1 | |
부착억제 | 인삼 또는 인진쑥추출물 | 0.5 | - | 0.5 | - | 0.3 | 0.3 | 0.1 | 0.1 |
락토바실러스 컨퓨서스(L.confusus)(cells/ml) | - | 1010 | - | 1010 | 108 | 108 | 107 | 107 | |
포도폴리페놀 | - | - | - | - | - | - | - | 0.1 | |
L-글루타민 | - | - | - | - | - | - | - | 0.5 | |
요구르트 베이스 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 | |
계 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
배합 예 | 평균 UBT 감소율(%) | 자가증상(위통, 복부팽만감)개선 정도 | |
실험군 | 대조군 | ||
배합 1 | 69.5 | +12.3 | ++ |
배합 2 | 72.1 | +8.0 | ++ |
배합 3 | 76.2 | +14.5 | +++ |
배합 4 | 76.4 | +5.3 | +++ |
배합 5 | 79.8 | +15.2 | ++ |
배합 6 | 75.4 | +11.7 | +++ |
배합 7 | 84.6 | +10.6 | +++ |
배합 8 | 84.8 | +9.8 | +++++ |
Claims (4)
- 위장 내 헬리코박터 피로리균의 균감소 및 증식억제 기능이 있는 요구르트 조성물에 있어서, 마스틱검 0.003∼0.34%, 인삼 추출물 또는 인진쑥 추출물 중 1종 이상 0.03∼0.5%, 마누카꿀 0.1∼5%, 헬리코박터 피로리 억제 유산균 107∼1010cells/ml 포함하는 것을 특징으로 하는 요구르트 조성물.
- 제1항에 있어서, 상기 유산균은 락토바실러스 코프로필러스(Lactobacillus coprophilus), 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 파라카세이(Lactobacillus paracasei), 락토바실러스 컨퓨서스(Lactobacillus confusus) 중 1종 이상인 것을 특징으로 하는 요구르트 조성물.
- 제1항 또는 제2항에 있어서, 활성산소 제거기능이 있는 폴리페놀 0.01∼0.2% 및 위벽 재생효과가 있는 L-글루타민 0.005∼0.5%을 부가하는 것을 특징으로 하는 요구르트 조성물.
- 제3항에 있어서, 상기 폴리페놀은 포도로부터 추출한 것임을 특징으로 하는 요구르트 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20010011990 | 2001-03-08 | ||
KR1020010011990 | 2001-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020072486A true KR20020072486A (ko) | 2002-09-16 |
KR100415591B1 KR100415591B1 (ko) | 2004-01-16 |
Family
ID=27696792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0023789A KR100415591B1 (ko) | 2001-03-08 | 2001-05-02 | 위장내 헬리코박터 피로리 감염균의 감소 및 증식억제능이 있는 요구르트 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100415591B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007100179A1 (en) * | 2006-02-28 | 2007-09-07 | Myeong-Hee Jung | Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread |
KR100851962B1 (ko) * | 2006-11-13 | 2008-08-12 | 주식회사 케이씨에프코리아 | 포도씨 추출물 함유 항-헬리코박터 파이로리 조성물 |
WO2012118535A1 (en) * | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4021951B2 (ja) * | 1996-03-01 | 2007-12-12 | わかもと製薬株式会社 | 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品 |
KR100319365B1 (ko) * | 1999-07-23 | 2002-01-09 | 이은선 | 위궤양의 예방 및 치료에 효과가 있는 생약 추출물 및 그 용도 |
KR100330138B1 (ko) * | 1999-10-29 | 2002-03-27 | 채문식 | 헬리코박터 파이로리의 세포 결합을 저해하는 인삼뿌리에서 분리된 산성다당류 및 이를 함유하는 위장병 예방 및 치료용 조성물 |
-
2001
- 2001-05-02 KR KR10-2001-0023789A patent/KR100415591B1/ko active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007100179A1 (en) * | 2006-02-28 | 2007-09-07 | Myeong-Hee Jung | Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread |
KR100851962B1 (ko) * | 2006-11-13 | 2008-08-12 | 주식회사 케이씨에프코리아 | 포도씨 추출물 함유 항-헬리코박터 파이로리 조성물 |
WO2012118535A1 (en) * | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
Also Published As
Publication number | Publication date |
---|---|
KR100415591B1 (ko) | 2004-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2533268C2 (ru) | Композиция для профилактики или лечения нарушений желудочно-кишечного тракта, содержащая в качестве активного ингредиента s-аллил-l-цистеин | |
KR101870960B1 (ko) | 락토바실러스 사케이 k040706을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물 | |
JP5898825B2 (ja) | 腸内有害菌低減剤、それを含む食品または医薬品 | |
JP2010285425A (ja) | 腸内細菌叢構成比率調整剤 | |
WO1998037874A1 (en) | Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection | |
TWI734322B (zh) | 用於預防或治療幽門螺旋桿菌相關疾病之韓國泡菜 | |
KR102230517B1 (ko) | 충치 억제 활성을 갖는 락토바실러스 살리바리우스를 포함하는 조성물 | |
KR19980703245A (ko) | 소화성 궤양 치료용 한약조성물 및 그 처리방법 | |
KR100415591B1 (ko) | 위장내 헬리코박터 피로리 감염균의 감소 및 증식억제능이 있는 요구르트 조성물 | |
Wan et al. | Effect of Lactobacillus acidophilus fermentation on the composition of chlorogenic acids and anti-hyperuricemia activity of Artemisia selengensis Turcz | |
US20240115644A1 (en) | Composition for preventing, improving or treating gastritis or peptic ulcer comprising extract of cinnamomum cassia, fraction of said extract, isolate of said fraction or compounds isolated therefrom | |
EP1525887A1 (en) | Drugs including anticancer agents and immunopotentiators and health foods and drinks | |
EP3569240A1 (en) | Composition for preventing or treating gastritis or peptic ulcer | |
KR101645721B1 (ko) | 위장질환 예방 및 치료용 유향 함유 조성물 | |
JP4633367B2 (ja) | 抗ヘリコバクター・ピロリ剤 | |
KR20180075763A (ko) | 마치현 주정 추출물을 유효성분으로 함유하는 알콜성 간손상 예방, 개선 및 치료용 조성물 | |
KR19990085818A (ko) | 감기의 치료 및 예방 기능을 갖는 항바이러스성 약제 및기능성 식품 | |
KR20200070080A (ko) | 충치 억제 활성을 갖는 락토바실러스 루테리 mg505 를 포함하는 조성물 | |
KR101367250B1 (ko) | 유산균을 포함하는 위염 억제/개선용 발효홍삼 | |
Silva | Evaluation of the antimicrobial potential of natural extracts on Helicobacter pylori | |
KR100855022B1 (ko) | 락토바실러스 파라플란타룸 knuc25를 포함하는헬리코박터 파이로리 생육 억제용 조성물 | |
Sasaki | Bioactive phytocompounds and products traditionally used in Japan | |
KR102237450B1 (ko) | 강황잎 추출물을 유효성분으로 포함하는 장기능 개선용 조성물 | |
JP2014080448A (ja) | 腸内バクテロイデス増殖促進剤 | |
CN111296759A (zh) | 一种具有保护胃黏膜功能的组合物、应用及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121218 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140207 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160205 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170104 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180105 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20181218 Year of fee payment: 16 |